Full Issue

Individual Articles - Sep/Oct 2026 - Volume 30, Number 5

Issue/Page View/Buy	Title/Author (Click for Abstract / Details / Purchase)
Sep/Oct 2026 Pg. 405-406	Prescription - “Inside Hospital or Health Systems Compounding: Culture, Compliance, and Care” Author(s): Kupiec Thomas C
Sep/Oct 2026 Pg. 407	Guest Editor’s Perspective - From Compliance to Culture Author(s): Wolman Mallory
Sep/Oct 2026 Pg. 409-418	Compounding Through Crisis: Developing Safe Processes During Drug Shortages Author(s): Wolman Mallory, Nguyen Peter H
Sep/Oct 2026 Pg. 419-432	Hospital Compounding: More Than a Pharmacy Issue Author(s): Alexander Michael R, Combs Blinn E, Earl Matthew D, Howard Brad
Sep/Oct 2026 Pg. 433-434	Unasyn® (Ampicillin Sodium and Sulbactam Sodium) Injection Author(s): Stockton Shelly J
Sep/Oct 2026 Pg. 435-436	Compounded Topical Powder for Post-Digital Amputation Care Author(s): Vu Nicole
Sep/Oct 2026 Pg. 437-442	Compounding Medications for Intrathecal Administration: Scientific Precision and Ethical Judgment Author(s): Pate Marshall, Moore W Mark, Asbill Scott
Sep/Oct 2026 Pg. 443-446	Topical Ketoprofen 5%, Amitriptyline HCL 5%, and Lidocaine 5% Compounded in VersaPro Cream for Diabetic Peripheral Neuropathy: A Case Report Author(s): McSwan Joyce, Haiub Halema
Sep/Oct 2026 Pg. 447-451	Long-Term Stability of a Fixed-Dose Doxazosin and Finasteride Combination Formulation Author(s): Mengesha Abebe, Hess Jared
Sep/Oct 2026 Pg. 453-462	Stability Testing of Intraventricular Irrigations Diluted in Lactated Ringer's Solution Author(s): Garavaglia Jeffrey M, DeBastiani Anthony, Peaslee Jessica, McClure Jesse, Brandmeir Nicholas
Sep/Oct 2026 Pg. 463-481	Container–closure Performance of an Airless Calibrated Pump for Compounded Topical Semisolids: Dispensed-mass Reproducibility, Barrier Properties, and Compatibility Author(s): Carolina Souza de Barros Gomes Anna, Schettino Kegele Carolina, Taylor Sarah, Polonini Hudson
Sep/Oct 2026 Pg. 483-499	Stability of Acyclovir, Aprepitant, Glibenclamide, and Mebendazole Oral Suspensions Compounded with SyrSpend® SF PH4 Author(s): Schettino Kegele Carolina, Taylor Sarah, Polonini Hudson
Sep/Oct 2026 Pg. 501-511	Crushability Assessment of Immediate-Release Oral Tablets and Capsules Approved by the FDA in 2023 and 2024 Author(s): Tzikas Christina, Saei Kamaladdin, Zhao Fang, Schweighardt Anne